Literature DB >> 15122677

Comparison of BOLD contrast and Gd-DTPA dynamic contrast-enhanced imaging in rat prostate tumor.

Lan Jiang1, Dawen Zhao, Anca Constantinescu, Ralph P Mason.   

Abstract

The microcirculation and oxygenation of a tumor play important roles in its responsiveness to cytotoxic treatment, and noninvasive assessments of its vascular properties may have prognostic value. Dynamic contrast-enhanced (DCE) (1)H MRI based on infusion of Gd-DTPA, and blood oxygen level-dependent (BOLD) contrast based on altering inhaled gas are both sensitive to vascular characteristics. This study compares the effects observed in eight Dunning prostate R3327-AT1 rat tumors imaged sequentially at 4.7 Tesla by echo-planar imaging (EPI). Both interventions generated a significant response, and each revealed significant differences between the center and periphery of the tumors. On a voxel-by-voxel basis across the whole tumor population, there was a close correlation between the maximum rate of signal response and the magnitude of response to each intervention (R(2) >or= 0.6, P < 0.0001). However, when the data were analyzed separately for each individual tumor, some showed a weak correlation (R(2) < 0.4), particularly for DCE, and the nature (slope) varied between separate tumors. Generally, there was a weak correlation (N = 7, R(2) < 0.5) between responses to the two interventions on a tumor-by-tumor basis, which emphasizes that the techniques are not equivalent. Both techniques revealed intra- and intertumor heterogeneity, but the BOLD response was more rapidly reversible than the DCE response. This suggests that the BOLD technique may be a useful tool for investigating interventions (such as drugs) that cause vascular disruption. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122677     DOI: 10.1002/mrm.20069

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  18 in total

1.  In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation.

Authors:  Jian Cao; James Campbell; Li Liu; Ralph P Mason; Alexander R Lippert
Journal:  Anal Chem       Date:  2016-04-15       Impact factor: 6.986

2.  The effect of flow on blood oxygen level dependent (R* 2 ) MRI of orthotopic lung tumors.

Authors:  Heling Zhou; Olivier Belzile; Zhang Zhang; Jo Wagner; Chul Ahn; James A Richardson; Debabrata Saha; Rolf A Brekken; Ralph P Mason
Journal:  Magn Reson Med       Date:  2019-01-30       Impact factor: 4.668

Review 3.  Translating preclinical MRI methods to clinical oncology.

Authors:  David A Hormuth; Anna G Sorace; John Virostko; Richard G Abramson; Zaver M Bhujwalla; Pedro Enriquez-Navas; Robert Gillies; John D Hazle; Ralph P Mason; C Chad Quarles; Jared A Weis; Jennifer G Whisenant; Junzhong Xu; Thomas E Yankeelov
Journal:  J Magn Reson Imaging       Date:  2019-03-29       Impact factor: 4.813

4.  Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T.

Authors:  Rami R Hallac; Yao Ding; Qing Yuan; Roderick W McColl; Jayanthi Lea; Robert D Sims; Paul T Weatherall; Ralph P Mason
Journal:  NMR Biomed       Date:  2012-05-23       Impact factor: 4.044

5.  Continuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology.

Authors:  Dawen Zhao; Lan Jiang; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

6.  GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.

Authors:  Praveen K Gulaka; Federico Rojas-Quijano; Zoltan Kovacs; Ralph P Mason; A Dean Sherry; Vikram D Kodibagkar
Journal:  J Biol Inorg Chem       Date:  2013-11-27       Impact factor: 3.358

7.  Dynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenation.

Authors:  Dawen Zhao; Jesús Pacheco-Torres; Rami R Hallac; Derek White; Peter Peschke; Sebastian Cerdán; Ralph P Mason
Journal:  NMR Biomed       Date:  2015-06-08       Impact factor: 4.044

8.  Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

Authors:  Marc Jennewein; Matthew A Lewis; Dawen Zhao; Edward Tsyganov; Nikolai Slavine; Jin He; Linda Watkins; Vikram D Kodibagkar; Sean O'Kelly; Padmakar Kulkarni; Peter P Antich; Alex Hermanne; Frank Rösch; Ralph P Mason; Philip E Thorpe
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

9.  Spin-lock imaging of intrinsic susceptibility gradients in tumors.

Authors:  Zhongliang Zu; Vaibhav Janve; John C Gore
Journal:  Magn Reson Med       Date:  2019-12-27       Impact factor: 4.668

Review 10.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; M H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.